2 Dividend Stocks to Buy for Decades of Passive Income
Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings.
They should maintain their dividend growth habits for a long time to come.
That's thanks to their solid businesses and promising product pipelines.
In 2013, AbbVie (NYSE: ABBV) became a publicly traded corporation after splitting from its former parent company, Abbott Laboratories (NYSE: ABT). Since then, both have produced strong returns and have been great picks for income-seeking investors, thanks to consistent payout hikes. That likely won't change soon.
These healthcare leaders should continue to perform well and reward shareholders with dividend increases for a long time. Read on to find out more.
1. AbbVie
AbbVie is a pharmaceutical leader with a large portfolio of approved products, none more important than a duo of immunology medicines: Skyrizi and Rinvoq. In the first quarter, the company's revenue increased by 8.4% year over year to $13.3 billion, while its adjusted earnings per share came in at $2.46, 6.5% higher than the year-ago period. These results are all the more impressive considering AbbVie faced a major patent cliff just two years ago; however, it has since recovered, largely thanks to Skyrizi and Rinvoq.
The former generated $3.4 billion in sales during the period, representing a 70.5% year-over-year increase. Rinvoq's revenue came in at $1.7 billion, 57.2% higher than the year-ago period. Management predicts their combined annual sales will exceed $31 billion by 2027. Not only is that significantly higher than the $17.7 billion they racked up last year, it's also $4 billion higher than their previous guidance.
Skyrizi and Rinvoq are expected to drive top-line growth well into the 2030s. Although they will eventually lose patent protection, they demonstrate AbbVie's ability to navigate even the biggest patent cliffs, a quality that is essential for any pharmaceutical company to thrive over the long term. AbbVie has other products that help drive revenue growth, and, equally important, it has a deep pipeline that it routinely strengthens through acquisitions.
In March, the company announced a licensing deal with Denmark-based Gubra A/S for GUB014295, an investigational weight management therapy. AbbVie paid $350 million up front for this candidate, with potential milestones of $1.9 billion, not including royalties. AbbVie entered the fast-growing weight loss market with this move; GUB014295 might not pan out, but AbbVie's large pipeline, with approximately 90 products in development, should allow it to launch brand-new products frequently, navigate patent cliffs, and remain successful over the long run.
Now turning to the company's dividend, AbbVie has increased its payouts by 310% since 2013. And counting the time it spent under Abbott Laboratories' name, AbbVie is a Dividend King with 53 consecutive years of payout increases. These facts, from AbbVie's underlying business to the company's dividend track record, point to a company capable of sustaining a passive income program for a long time.
2. Abbott Laboratories
Abbott Laboratories is best known for its leadership in the medical device space, where it markets dozens of products across multiple therapeutic areas. The company also operates a diagnostic business and has a presence in the pharmaceutical and nutrition industries. Abbott Laboratories' operations are diversified, which can help it overcome challenges in specific segments. That's one of the company's strengths.
Here's another: Abbott Laboratories has been a leader in the highly regulated healthcare sector for decades. The company has built a solid reputation with physicians and consumers, all of whom are more likely to gravitate toward the brands they know and trust. In the medical device field, Abbott is a trusted brand. And thanks to its vast portfolio, it generates consistent revenue and earnings.
Abbott's biggest growth driver in recent years has been its diabetes care segment, led by its continuous glucose monitoring (CGM) franchise, the FreeStyle Libre. As the company noted, the FreeStyle Libre has become the most successful medical device in history in terms of dollar sales. That's no small feat. Yet there is still massive whitespace ahead, since only a small portion of the world's diabetics use CGM technology despite its advantages.
Abbott's work in this niche should provide a powerful long-term tailwind, but there will be many others. The company boasts other growth drivers, including its structural heart segment, where it markets a range of successful devices, such as its MitraClip device, a leader in its mitral valve repair niche. Beyond any single product, Abbott Laboratories has a proven track record as an innovator and should continue launching newer and better ones.
Lastly, Abbott is also a Dividend King, and over the past decade, it has increased its payouts by almost 146%. Abbott Laboratories' business is built to last. Investors who purchase the company's shares today can expect consistent dividend growth over the long term.
Should you invest $1,000 in AbbVie right now?
Before you buy stock in AbbVie, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AbbVie wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!*
Now, it's worth noting Stock Advisor 's total average return is1,060% — a market-crushing outperformance compared to180%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 30, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
3 hours ago
- Globe and Mail
Durant trade to Houston a seven-team, history-making deal
Kevin Durant's trade to the Houston Rockets is official and officially record-setting. The deal got approved by the NBA on Sunday as part of a seven-team transaction, one in which a slew of other trade agreements got folded into one massive package. 'Kevin impacts the game on both ends of the court and is one of the most efficient scorers in the history of basketball,' Rockets general manager Rafael Stone said. 'We liked the growth our team showed last season and believe Kevin's skill set will integrate seamlessly.' Involved in the deal: Phoenix, Houston, Atlanta, Minnesota, Golden State, Brooklyn and the Los Angeles Lakers. It includes a total of 13 players — the headline moves include Durant going to Houston from Phoenix, the Rockets sending Jalen Green and Dillon Brooks to the Suns, and the Rockets acquiring Clint Capela from the Hawks. The seven-team involvement in the Durant trade tops the previous record, a six-team transaction last summer that most notably sent Klay Thompson to the Dallas Mavericks. Golden State — Thompson's former team — obviously was another part of that trade, as were Charlotte, Minnesota, Philadelphia and Denver on varying levels. 'One of the greatest to ever play the game, we are grateful for the impact Kevin made on our organization and in our community,' Phoenix general manager Brian Gregory said of Durant. 'As a member of the Suns, he climbed the scoring charts to become just the eighth player in NBA history to score 30,000 career points, and we wish him the best as he continues his career in Houston.' There will be at least five second-round draft picks in the deal before all terms are satisfied, the potential for another second-round pick swap and the Hawks and Timberwolves both had to receive some cash considerations to make all the math work. And some of those draft picks won't actually be made until 2032, which raises the serious possibility that some players who will go down in history as being part of the trade haven't reached high school yet. Durant averaged 26.6 points last season, his 17th in the NBA — not counting one year missed because of injury. For his career, the 6-foot-11 forward is averaging 27.2 points and seven rebounds per game. The move brings Durant back to the state of Texas, where he played his only year of college basketball for the Longhorns and was the college player of the year before going as the No. 2 pick in the 2007 draft by Seattle. Houston becomes his fifth franchise, joining the SuperSonics (who then became the Oklahoma City Thunder), Golden State, Brooklyn and Phoenix. Durant won his two titles with the Warriors in 2017 and 2018, and last summer in Paris he became the highest-scoring player in U.S. Olympic basketball history and the first men's player to be part of four gold-medal teams. Durant is a four-time scoring champion, a two-time Finals MVP and one of eight players in NBA history with more than 30,000 career points. 'Having played against Kevin and coached him before, I know he's the type of competitor who fits with what we've been building here in Houston,' Rockets coach Ime Udoka said. 'His skill level, love of basketball, and dedication to his craft have made him one of the most respected players of his generation, and my staff and I are excited to work with him.' Houston sent Green and Brooks to Phoenix, along with the rights to Khaman Maluach from last month's draft, a second-round pick in 2026 and another second-rounder in 2032. The Hawks got David Roddy, cash and a 2031 second-round pick swap from the Rockets. Brooklyn gets a 2026 second-round pick and another in 2030 from the Rockets, and the Warriors received the rights to Jahmai Mashack from last month's draft.
CBC
4 hours ago
- CBC
Trump's global tariff pause is supposed to expire soon. What's at stake for Canada?
U.S. President Donald Trump's three-month pause on his sweeping global tariffs is set to expire in just a few days, unless he opts to give countries extra time to negotiate deals — as his advisers have suggested this weekend. Ahead of the deadline, some trade experts say Canada still faces big risks, despite avoiding that round of levies back in April. "What the president needs is a bunch of wins by July 9 because he needs to show that his strategy is working," said Inu Manak, a fellow for trade policy at the Council on Foreign Relations, during an interview with CBC's The House that aired Saturday. On April 2, Trump held up a list in the Rose Garden of the White House and announced what he called "reciprocal tariffs" on more than 150 countries, including China and the European Union. The rates for individual countries on the list varied from 10 per cent to more than 40 per cent. Canada wasn't on that list, though other tariffs Trump had previously imposed on Canadian goods remained. One week after he unveiled the list, the president backed down and said he would freeze the global tariffs for 90 days to allow each country to negotiate deals with his administration. The problem for Canada is Trump hasn't closed many deals in those 90 days, Manak said. So far, the U.S. has reached agreements with Britain and Vietnam. Negotiations with other top markets like China, India, the European Union and Japan are ongoing. "If we don't see a lot of deals coming out of this, what we're likely to see is [Trump] to get more agitated and ask for more concessions from the countries that he knows he can push a little harder," Manak said. "So I think for Canada, that would be a very bad situation." Carlo Dade, international policy director at the University of Calgary's School of Public Policy, told CBC News "there's a risk every day of the week that [Trump] decides to come after Canada. That is not an exaggeration." "We're open to this potential as long as the president has unrestrained power to implement tariffs whenever, wherever, however he wants," he said. Trump used a law called the International Emergency Economic Powers Act (IEEPA) to apply the worldwide tariffs and his earlier fentanyl tariffs on Canada and Mexico. The law is intended to address "unusual and extraordinary" threats during national emergencies. In late May, the New York-based U.S. Court of International Trade ruled Trump exceeded his authority by invoking IEEPA. The White House swiftly appealed and a federal appeals court allowed IEEPA tariffs to remain in effect while it reviewed the decision. WATCH | Europe gets a reprieve on tariffs: Trump delays tariff threat on EU to July 1 month ago Duration 2:52 U.S. President Donald Trump says he will delay his 50 per cent tariff on imports from the European Union until July 9 after a weekend phone call between Trump and European Commission President Ursula von der Leyen. Manak said another challenge is Trump isn't facing political consequences for his tariffs right now — and no major economic fallout, either. "Right now, he's kind of sitting at a point where he feels he can kind of get away with maintaining the pressure that exists. And that pressure is enough to get other countries to the table," she said. At a White House news conference at the end of June, Trump told reporters the U.S. "can do whatever we want. We could extend [the July 9 deadline]. We could make it shorter. I'd like to make it shorter." On Sunday, U.S. Treasury Secretary Scott Bessent suggested the July 9 deadline is being pushed back by about a month. He said on CNN's State of the Union that the Trump administration would send letters to trading partners "saying that if you don't move things along, then on Aug. 1 you will boomerang back to your April 2 tariff level." "So I think we're going to see a lot of deals very quickly," Bessent told host Dana Bash. He also said Aug. 1 is "not a new deadline." Commerce Secretary Howard Lutnick told reporters Sunday the higher tariffs would take effect on Aug. 1, but Trump was "setting the rates and the deals right now." Is there opportunity for Canada? Fen Osler Hampson, co-chair of the Expert Group on Canada-U.S. Relations at Carleton University, said Canada could leverage the economic uncertainty from Trump's tariffs and "put the pedal to the metal" to expand trade with European and Asian allies. Hampson added that Canada already has good trading relationships with those regions through the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) and the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP). WATCH | Trump isn't pleased with taunts of 'chickening out' on trade: Does Trump 'always chicken out' on tariffs? 1 month ago Duration 5:34 Investors are poking fun at U.S. President Donald Trump's on-again, off-again tariff threats, calling it 'TACO' trade — which stands for 'Trump Always Chickens Out.' When asked about the term, Trump called it a 'nasty question.' CBC's Katie Simpson reports. With U.S. tariffs, Hampson said those countries are "going to be looking for other market opportunities, both to sell and buy. I think our challenge is to get serious and to realize the real dividends that can come from those two major regional trading agreements." Diversifying Canada's trading partners is one of Prime Minister Mark Carney's top goals — and a key objective for International Trade Minister Maninder Sidhu. "I think Canada has a lot to offer and we should be screaming that at the top of our lungs," Sidhu told CBC's The House in an interview that aired Saturday. Canada has already deepened its trade relationships with countries such as Ecuador and the United Arab Emirates since Carney and Sidhu came into office. But key markets that could make a big dent in easing Canada's reliance on U.S. trade — like the U.K., India and China — are thornier due to fraught diplomatic relationships and other irritants. Colin Robertson, a former Canadian diplomat and vice-president at the Canadian Global Affairs Institute, agreed that Canada can do more trade with other countries, but added a note of caution: businesses, not governments, are the only ones who can decide which companies they trade with. "Ultimately, business has to see a business opportunity," Robertson said, adding that the U.S. continues to be the market with the easiest access for Canadian businesses. On The House, Sidhu told guest host Janyce McGregor that Canadian businesses were indeed comfortable dealing with the U.S., but now they're asking him to help facilitate access to more countries. Canada-U.S. trade talks Carney and Trump continue to negotiate a Canada-U.S. trade deal, after setting a deadline of July 21. Hampson said the deadline helps Canada hold the Americans' attention as the Trump administration negotiates with other countries. The Americans also have an interest in getting a deal done soon, Robertson said. Canada and U.S. restarted negotiations Monday morning, Carney says 6 days ago Duration 1:15 Prime Minister Mark Carney says he had a 'good' conversation with U.S. President Donald Trump on Sunday, and that the two leaders will keep working to reach a deal by July 21. The federal government scrapped the digital services tax over the weekend after Trump paused all trade talks. "If [the Americans] can't do it with Canada, their ally and their partner, it's much harder to do with Mexico, much harder with China," he said. "We should be the lowest of the hanging fruit from the American perspective." Trade discussions hit a roadblock in late June when Trump announced he would walk away from the negotiating table over Canada's digital services tax. The federal government scrapped the tax a few days later and discussions got back on track. Robertson said he's a bit skeptical about how far Canada will get with the U.S. by July 21, but adds that Trump enjoys declaring victory even if the agreement is "only 80 per cent of the way there." "Would we settle for 80 per cent? Be basically there and leave the rest to be cleaned up? I think so," he said. "Because if Trump's taken his eye off it and says it's basically there, then that's sufficient from where we're coming from."
Globe and Mail
4 hours ago
- Globe and Mail
Higher tariffs to take effect August 1, U.S. Commerce Secretary Lutnick says
U.S. President Donald Trump on Sunday said some trade deals had been made with trading partners and letters would go out to other countries notifying them of higher tariff rates. Commerce Secretary Howard Lutnick told reporters that the higher tariffs would take effect on August 1, but Trump was 'setting the rates and the deals right now.' Bessent says U.S. close to several trade deals ahead of July 9 tariff deadline Trump in April announced a 10-per-cent base tariff rate on most countries and higher additional rates ranging up to 50 per cent, although he later delayed the effective date for all but 10 per cent until July 9. Lutnick's comments indicate a three-week reprieve.
